CFO received an award of 2,926 CRL shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 6, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 7, 2025
CFOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001100682-25-000045
- Filed / recorded
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerCHARLES RIVER LABORATORIES INTERNATIONAL, INC. Reporting personMichael Gunnar Knell Officer titleCSVP, CAO, Interim CFO TableNon-derivative (Table I) Transaction dateNov 6, 2025 Acquired / disposedAcquired (A) Footnotes from the filing
- 50% of the unvested restricted stock units vest on November 6, 2026, with the remaining 50% vesting on November 6, 2027.
Around the same time
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
